Martin H Voss

Title: Martin H Voss: Innovator in Cancer Therapeutics

Introduction

Martin H Voss is a prominent inventor based in New York, NY (US), known for his significant contributions to cancer research. He has developed innovative methods to evaluate the effectiveness of rapamycin analogs in treating cancer. His work is particularly focused on understanding the genetic factors that influence therapeutic responses in patients.

Latest Patents

Martin H Voss holds a patent titled "Biomarkers for response to rapamycin analogs." This invention relates to the use of specific biomarkers to assess the likelihood of an anti-cancer effect from rapamycin analogs in patients. The patent is based on experiments that utilized next-generation sequencing to analyze tumor specimens, revealing critical insights into intra-tumor and intertumor heterogeneity. The findings indicate that mutations in TSC1 and TSC2, as well as gain-of-function mutations in mTOR, play a significant role in the therapeutic responsiveness to rapamycin analogs. The invention also provides assay methods and kits for detecting these mutations, which can aid in selecting appropriate treatment regimens for cancer patients.

Career Highlights

Martin H Voss is affiliated with the Memorial Sloan Kettering Cancer Center, where he conducts groundbreaking research in oncology. His work has been instrumental in advancing the understanding of cancer treatment and improving patient outcomes. With a focus on personalized medicine, Voss's research aims to tailor therapies based on individual genetic profiles.

Collaborations

Martin has collaborated with notable colleagues, including James Hsieh and Michael Berger. These partnerships have fostered a collaborative environment that enhances the research and development of innovative cancer therapies.

Conclusion

Martin H Voss is a key figure in the field of cancer therapeutics, with a focus on the genetic determinants of treatment response. His patent on biomarkers for rapamycin analogs represents a significant advancement in personalized cancer treatment. Through his work at Memorial Sloan Kettering Cancer Center, Voss continues to contribute to the fight against cancer, improving the lives of patients through innovative research.